Medullary thyroid carcinoma.
Modigliani
E
E
Paris XIII University, France.
D000310:Adrenal Gland Neoplasms / Q000601:surgery; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001971:Bromocriptine / Q000627:therapeutic use; D018276:Carcinoma, Medullary / Q000235:genetics / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D007980:Levodopa / Q000627:therapeutic use; D008197:Lymph Node Excision; D008207:Lymphatic Metastasis; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D015282:Octreotide / Q000627:therapeutic use; D010673:Pheochromocytoma / Q000601:surgery; D012008:Recurrence; D015996:Survival Rate; D013964:Thyroid Neoplasms / Q000235:genetics / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D013965:Thyroidectomy
D000970:Antineoplastic Agents; D007457:Iodine Radioisotopes; D001971:Bromocriptine; D007980:Levodopa; D015282:Octreotide